Know Cancer

or
forgot password

Development of a Clinical Trial Specific Question Prompt List


N/A
18 Years
N/A
Not Enrolling
Both
Breast Cancer, Lung Cancer, Prostate Cancer

Thank you

Trial Information

Development of a Clinical Trial Specific Question Prompt List


Inclusion Criteria:



- Population Segment 1 who have participated in a clinical trial

- Diagnosis and treatment at MSKCC of lung, prostate or breast cancer

- Completion of a Phase I, II, or III clinical trial at MSKCC

- Ability to provide informed consent

Patient caregiver eligibility requirements will be:

- Nomination by patient as the primary caregiver

- Ability to provide informed consent

Population Segment 2 who have not participated in a clinical trial:

- Diagnosis and treatment at MSKCC of lung, prostate or breast cancer or the primary
patient caregiver

- Ability to provide informed consent

Patient caregiver eligibility requirements will be:

- Nomination by patient as the primary caregiver

- Ability to provide informed consent

Population Segment 3 who are health care professionals:

- A current health care professional at MSKCC

- Current involvement in recruiting patients with lung, prostate or breast cancer to
Phase I,II, or III clinical trials at MSKCC

- Ability to provide informed consent

Exclusion Criteria:

Potential subjects will be considered ineligible for either/both phases of this study if
they are:

- Fewer than 18 years of age

- Cognitively or physically impaired, rendering them incapable of providing informed
consent to participate in the study

- Population Segment 2 participants will be excluded if they have ever participated in
a clinical trial.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To develop a targeted Question Prompt List for Clinical Trials and evaluate its acceptability to cancer patients considering clinical trial participation.

Outcome Time Frame:

conclusion of study

Safety Issue:

No

Principal Investigator

Carmen Bylund, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

08-042

NCT ID:

NCT00662324

Start Date:

April 2008

Completion Date:

May 2013

Related Keywords:

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Breast Neoplasms
  • Lung Neoplasms
  • Prostatic Neoplasms

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021